GSK plc (LSE:GSK) is a British multinational pharmaceutical and biotechnology company founded in 1715, making it one of the world's oldest pharmaceutical companies. The company was formed through a series of mergers, most notably the 2000 merger of Glaxo Wellcome and SmithKline Beecham, and changed its name from GlaxoSmithKline plc to GSK plc in May 2022. Headquartered in Brentford, United Kingdom, GSK has evolved from a traditional pharmaceutical company into a focused biopharmaceutical enterprise specializing in vaccines and specialty medicines. The company operates globally with significant presence in the United States, Europe, and emerging markets, dedicating its efforts to preventing and treating diseases through innovative research and development.
$49.57
+1.12%Price chart
Sep 17Sep 22Sep 25Sep 30Oct 5Oct 8Oct 13Oct 16
Key dataOct 16, 2026
Open$49.62
From 52W high−18.98%
Volume4.86M
Market cap$99.31B
P/E (TTM)15.6x
P/S (TTM)2.3x
Div yield3.66%
Key dataOct 16, 2026
Open
$49.62
From 52W high
−18.98%
Volume
4.86M
Market cap
$99.31B
ValuationView details →
P/E (Fwd)
9.7x
EV/EBITDA
10.2x
P/E (TTM)
15.6x
RSI (14)
56.8
MomentumView details →
1D Return
+1.12%
YTD Return
+1.20%
SummaryUpdated Jun 1, 2026
Latest newsMore news →
Chia Tai Tianqing said its strategic-cooperation product Bepirovirsen was selected for two oral presentations and eight poster presentations at the 2026 AASLD annual meeting.2d agoBelgian Prime Minister Bart De Wever is set to meet GSK plc and its employees to discuss a restructuring plan.2d agoGSK plc informed Belgian unions of a proposed workforce reduction expected to affect 1,217 positions, including 735 management and 482 administrative roles.2d ago